Related Experiment Videos
Corynebacterium parvum as an immunotherapeutic anticancer agent
Seminars in Oncology
|December 1, 1974
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Reversible phosphorylation at the C-terminal regulatory domain of p21(Waf1/Cip1) modulates proliferating cell nuclear antigen binding.
The Journal of biological chemistry·2001
Height and weight in cystic fibrosis: a cross sectional study. UK Cystic Fibrosis Survey Management Committee.
Archives of disease in childhood·1998
Incidence, population, and survival of cystic fibrosis in the UK, 1968-95. UK Cystic Fibrosis Survey Management Committee.
Archives of disease in childhood·1998
From imaging to action: MRI features direct surgical strategy in low rectal cancer.
Seminars in oncology·2026
Regulation of PD-1 and PD-L1 expression in tumor immune microenvironment.
Seminars in oncology·2026
BEACON-HCC: Best evidence and north american consensus on treatment allocation for hepatocellular carcinoma.
Hepatology (Baltimore, Md.)·2026
Hydrogel-dependent strategies to modulate the tumor microenvironment for improved anti-tumor treatment.
International journal of pharmaceutics·2026
Aloe vera extract disrupts mitochondrial bioenergetics and suppresses HeLa cervical cancer cell proliferation: Transcriptomic and metabolic insights into cisplatin co-treatment.
Journal of bioenergetics and biomembranes·2026
Harmine reduces ROS-mediated hepatotoxicity in a cisplatin mouse model.
Research in pharmaceutical sciences·2026
Revisiting the literature on gastric CBD-to-THC conversion: contextualizing conflicting evidence.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences·2026